Ann H. Cory

2.9k total citations · 1 hit paper
35 papers, 2.5k citations indexed

About

Ann H. Cory is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Ann H. Cory has authored 35 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 21 papers in Oncology and 8 papers in Organic Chemistry. Recurrent topics in Ann H. Cory's work include Cancer-related Molecular Pathways (10 papers), Metal complexes synthesis and properties (7 papers) and DNA Repair Mechanisms (6 papers). Ann H. Cory is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Metal complexes synthesis and properties (7 papers) and DNA Repair Mechanisms (6 papers). Ann H. Cory collaborates with scholars based in United States. Ann H. Cory's co-authors include Joseph G. Cory, Terence C. Owen, J. A. Barltrop, Alan C. Sartorelli, Rick A. Finch, Germana Rappa, Aurelio Lorico, John W. Sibert, Tai‐Shun Lin and Mao‐Chin Liu and has published in prestigious journals such as Journal of Biological Chemistry, Chemical Communications and Biochemical and Biophysical Research Communications.

In The Last Decade

Ann H. Cory

35 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of an Aqueous Soluble Tetrazolium/Formazan Assay for Cell Growth Assays in Culture

1991 1.3k citations Ann H. Cory, Terence C. Owen et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ann H. Cory United States	14	1.1k	609	439	198	196	35	2.5k
Yasuo Hata Japan	27	1.3k 1.2×	356 0.6×	303 0.7×	449 2.3×	116 0.6×	97	2.8k
Adam Opolski Poland	29	762 0.7×	543 0.9×	793 1.8×	93 0.5×	101 0.5×	117	2.5k
Marc Devocelle Ireland	29	1.3k 1.2×	320 0.5×	448 1.0×	241 1.2×	108 0.6×	83	2.4k
Peter F. Searle United Kingdom	34	2.0k 1.9×	583 1.0×	217 0.5×	230 1.2×	174 0.9×	71	3.9k
Youngjoo Byun South Korea	29	1.1k 1.0×	580 1.0×	379 0.9×	374 1.9×	122 0.6×	137	3.5k
Terence C. Owen United States	16	1.1k 1.0×	264 0.4×	438 1.0×	204 1.0×	143 0.7×	50	2.6k
Vı́ctor M. González Spain	26	1.3k 1.2×	569 0.9×	456 1.0×	141 0.7×	121 0.6×	99	2.4k
Sharon La Fontaine Australia	30	983 0.9×	1.2k 1.9×	190 0.4×	188 0.9×	139 0.7×	52	3.7k
K.L. Kavanagh United Kingdom	32	2.8k 2.6×	889 1.5×	287 0.7×	492 2.5×	297 1.5×	56	4.7k
Jingxin Wang United States	32	1.8k 1.7×	329 0.5×	593 1.4×	138 0.7×	437 2.2×	85	3.1k

Countries citing papers authored by Ann H. Cory

Since Specialization

Citations

This map shows the geographic impact of Ann H. Cory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann H. Cory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann H. Cory more than expected).

Fields of papers citing papers by Ann H. Cory

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann H. Cory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann H. Cory. The network helps show where Ann H. Cory may publish in the future.

Co-authorship network of co-authors of Ann H. Cory

This figure shows the co-authorship network connecting the top 25 collaborators of Ann H. Cory. A scholar is included among the top collaborators of Ann H. Cory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann H. Cory. Ann H. Cory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cory, Ann H. & Joseph G. Cory. (2007). Understanding interactions between and among apoptosis inducing pathways in tumor cells.. PubMed. 21(2). 245–9. 2 indexed citations

Dinkova‐Kostova, Albena T., Ann H. Cory, Richard E. Bozak, Ronald J. Hicks, & Joseph G. Cory. (2006). Bis(2-hydroxybenzylidene)acetone, a potent inducer of the phase 2 response, causes apoptosis in mouse leukemia cells through a p53-independent, caspase-mediated pathway. Cancer Letters. 245(1-2). 341–349. 19 indexed citations

Cory, Ann H. & Joseph G. Cory. (2005). Induction of apoptosis in p53-deficient L1210 cells by an I-κ-B-α-inhibitor (Bay 11-7085) via a NF-κ-B-independent mechanism. Advances in Enzyme Regulation. 45(1). 85–93. 3 indexed citations

Cory, Ann H. & Joseph G. Cory. (2004). Gemcitabine-induced apoptosis in a drug-resistant mouse leukemia L1210 cell line that does not express p53. Advances in Enzyme Regulation. 44(1). 11–25. 3 indexed citations

Sibert, John W., Ann H. Cory, & Joseph G. Cory. (2002). Lipophilic derivatives of cyclam as new inhibitors of tumor cell growth. Chemical Communications. 154–155. 53 indexed citations

Cory, Ann H. & Joseph G. Cory. (2002). Augmentation of apoptosis responses in p53-deficient L1210 cells by compounds directed at blocking NFkappaB activation.. PubMed. 21(6A). 3807–11. 12 indexed citations

Cory, Joseph G., et al.. (2000). Phenotypic changes in mouse leukemia L1210 cells with alterations in the effector-binding subunit of ribonucleotide reductase. Advances in Enzyme Regulation. 40(1). 3–15. 2 indexed citations

Hall, Jennifer G., Ann H. Cory, & Joseph G. Cory. (1999). Lack of competition of substrates for P-glycoprotein in MCF-7 breast cancer cells overexpressing MDR1. Advances in Enzyme Regulation. 39(1). 113–128. 7 indexed citations

Cory, Ann H., et al.. (1998). Cellular Responses in Mouse Leukemia L1210 Cells Made Resistant to Deoxyadenosine. Biochemical and Biophysical Research Communications. 249(3). 687–691. 2 indexed citations

10.

Cory, Ann H., et al.. (1998). Multifactorial mechanisms of drug resistance in tumor cell populations selected for resistance to specific chemotherapeutic agents. Advances in Enzyme Regulation. 38(1). 3–18. 7 indexed citations

11.

Cory, Joseph G., Ann H. Cory, Aurelio Lorico, Germana Rappa, & Alan C. Sartorelli. (1998). Altered efflux properties of mouse leukemia L1210 cells resistant to 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.. PubMed. 17(5A). 3185–93. 12 indexed citations

12.

Rappa, Germana, Aurelio Lorico, Mao‐Chin Liu, et al.. (1997). Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductase. Biochemical Pharmacology. 54(6). 649–655. 30 indexed citations

13.

Cory, Joseph G., Ann H. Cory, Germana Rappa, et al.. (1995). Structure-function relationships for a new series of pyridine-2-carboxaldehyde thiosemicarbazones on ribonucleotide reductase activity and tumor cell growth in culture and in vivo. Advances in Enzyme Regulation. 35. 55–68. 33 indexed citations

14.

Cory, Ann H., Vicente Sámano, Morris J. Robins, & Joseph G. Cory. (1994). 2′-deoxy-2′-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in culture. Biochemical Pharmacology. 47(2). 365–371. 17 indexed citations

15.

Cory, Ann H. & Joseph G. Cory. (1994). Use of nucleoside kinase-deficient mouse leukemia L1210 cell lines to determine metabolic routes of activation of antitumor nucleoside analogs. Advances in Enzyme Regulation. 34. 1–12. 1 indexed citations

16.

Cory, Joseph G., Ann H. Cory, Germana Rappa, et al.. (1994). Inhibitors of ribonucleotide reductase. Biochemical Pharmacology. 48(2). 335–344. 97 indexed citations

17.

Cory, Joseph G., et al.. (1993). Structural aspects of N-hydroxy-N′-aminoguanidine derivatives as inhibitors of L1210 cell growth and ribonucleotide reductase activity. Advances in Enzyme Regulation. 33. 129–140. 5 indexed citations

18.

Cory, Ann H., Terence C. Owen, J. A. Barltrop, & Joseph G. Cory. (1991). Use of an Aqueous Soluble Tetrazolium/Formazan Assay for Cell Growth Assays in Culture. PubMed. 3(7). 207–212. 1283 indexed citations breakdown →

19.

Barltrop, J. A., Terence C. Owen, Ann H. Cory, & Joseph G. Cory. (1991). 5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl)tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans As cell-viability indicators. Bioorganic & Medicinal Chemistry Letters. 1(11). 611–614. 383 indexed citations

20.

Simonet, L, et al.. (1988). Liver microsomal inactivation of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone as an inhibitor of ribonucleotide reductase.. PubMed. 48(22). 6375–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact